Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane with Carboplatin and IMRT in Head and Neck Cancer
NCT00570674Phase 2Terminated
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Nov 2007
- Primary completion
- Oct 2013
- Modality
- Polymer-based Nanoparticles, Small Molecules
01
Overview
A Phase 2 trial of nab-paclitaxel in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Dana-Farber Cancer Institute. Started Nov 2007; status: terminated.
02
Drugs
nab-paclitaxel
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00570674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00570674.